BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22402725)

  • 21. Levetiracetam may favorably affect seizure outcome after temporal lobectomy.
    Jehi LE; Irwin AI; Kayyali H; Vadera S; Bingaman W; Najm I
    Epilepsia; 2012 Jun; 53(6):979-86. PubMed ID: 22462729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seizures in patients with glioma treated with phenytoin and levetiracetam.
    Merrell RT; Anderson SK; Meyer FB; Lachance DH
    J Neurosurg; 2010 Dec; 113(6):1176-81. PubMed ID: 20560728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy.
    Vajda FJ; O'Brien T; Lander C; Graham J; Eadie M
    Epilepsia; 2014 Aug; 55(8):1229-34. PubMed ID: 24995555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levetiracetam in pediatrics.
    Vigevano F
    J Child Neurol; 2005 Feb; 20(2):87-93. PubMed ID: 15794171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of levetiracetam in patients with epilepsy and interictal epileptiform discharges.
    Stodieck S; Steinhoff BJ; Kolmsee S; van Rijckevorsel K
    Seizure; 2001 Dec; 10(8):583-7. PubMed ID: 11792161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of levetiracetam in partial seizures.
    Devinsky O; Elger C
    Epileptic Disord; 2003 May; 5 Suppl 1():S27-31. PubMed ID: 12915338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary efficacy of levetiracetam in monotherapy.
    Ben-Menachem E
    Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of levetiracetam in refractory seizures due to a rare progressive myoclonic epilepsy: Lafora body disease.
    Hashmi M; Saleem F; Mustafa MS; Sheerani M; Ehtesham Z; Siddiqui K
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levetiracetam for mood stabilization and maintenance of seizure control following multiple treatment failures.
    Stoner SC; Lea JW; Wolf AL; Berges AA
    Ann Pharmacother; 2005 Nov; 39(11):1928-31. PubMed ID: 16204388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonepileptic seizures under levetiracetam therapy.
    Ignatenco A; Arzy S; Ghika J; Genoud D; Kaplan PW; Groppa S; Seeck M
    Epilepsy Behav; 2010 Nov; 19(3):526-7. PubMed ID: 20934390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberous sclerosis successfully treated with levetiracetam monotherapy: 18 months of follow-up.
    Papacostas SS; Papathanasiou ES; Myrianthopoulou P; Stylianidou G
    Pharm World Sci; 2007 Aug; 29(4):350-2. PubMed ID: 17333500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New observations in primary and secondary reading epilepsy: excellent response to levetiracetam and early spontaneous remission.
    Haykal MA; El-Feki A; Sonmezturk HH; Abou-Khalil BW
    Epilepsy Behav; 2012 Apr; 23(4):466-70. PubMed ID: 22386591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Early Posttraumatic Seizures in Children With Moderate to Severe Traumatic Brain Injury Despite Levetiracetam Prophylaxis.
    Chung MG; O'Brien NF
    Pediatr Crit Care Med; 2016 Feb; 17(2):150-6. PubMed ID: 26669640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levetiracetam-induced acute psychosis in a child.
    Zaki SA; Gupta S
    Indian J Pharmacol; 2014; 46(3):341-2. PubMed ID: 24987186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levetiracetam as monotherapy for seizures in a neonate with acute lymphoblastic leukemia.
    Ledet DS; Wheless JW; Rubnitz JE; Brannon Morris E
    Eur J Paediatr Neurol; 2010 Jan; 14(1):78-9. PubMed ID: 19186085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and safety of levetiracetam (keppra) add-on treatment in adult patients with refractory epilepsy in two tertiary centers].
    Auriel E; Chistik V; Blatt I; Margolin N; Neufeld M
    Harefuah; 2007 Apr; 146(4):269-71, 318. PubMed ID: 17476932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of levetiracetam in the treatment of epilepsy.
    Brodie MJ; French JA
    Epileptic Disord; 2003 May; 5 Suppl 1():S65-72. PubMed ID: 12915344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective study of the use of levetiracetam in childhood seizure disorders.
    Koukkari MW; Guarino EJ
    J Child Neurol; 2004 Dec; 19(12):944-7. PubMed ID: 15704867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam.
    Kobayashi K; Takeuchi A; Oka M; Akiyama M; Ohtsuka Y
    Brain Dev; 2012 May; 34(5):368-71. PubMed ID: 21889282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggravation of atonic seizures by rufinamide: A case report.
    Bektaş G; Çalışkan M; Aydın A; Pembegül Yıldız E; Tatlı B; Aydınlı N; Özmen M
    Brain Dev; 2016 Aug; 38(7):654-7. PubMed ID: 26906013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.